Skip to main content

Table 1 (abstract P369). See text for description

From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)

Disease

Age (years, mean, range)

Male (n,%)

COVID-19 symptoms (n,%)

COVID-19 serology (IgG positive, n,%)

COVID-19 PCR (positive, n,%)

Family history of COVID-19 (n,%)

MIS-C/ PIMS-TS (n=7)

8.4 (4-15)

3 (42.8%)

3 (42.8%)

5 (71.4%)

3 (42.8%)

4 (57.1%)

Henoch- Schonlein purpura (n=2)

10 (7-13)

1 (50%)

0

2 (100%)

0

2 (100%)

Miller Fisher syndrome (n=1)

15

1 (100%)

1 (100%)

1 (100%)

0

1 (100%)

Erythema nodosum (n=1)

3

1 (100%)

0

1 (100%)

0

1 (100%)

Covid toes (n=1)

18

1 (100%)

1 (100%)

1 (100%)

0

1 (100%)

  1. MIS-C (multisystem inflammatory syndrome in children); PIMS-TS (pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection)